Skip to main content
SpringerLink
Log in

Are adverse drug reactions to anti-diabetic drugs more common in patients whose treatment do not adhere to diabetes management clinical guidelines? Comments on a study report

  • Letter to the Editor
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Data Availability

Not applicable.

References

  1. Elangwe A, Katte J-C, Tchapmi D, Figueras A, Mbanya JC (2020) Adverse drug reactions to anti-diabetic drugs are commonest in patients whose treatment do not adhere to diabetes management clinical guidelines: cross-sectional study in a tertiary care service in sub-Saharan Africa. Eur J Clin Pharmacol 76(11):1601–1605. https://doi.org/10.1007/s00228-020-02949-2

    Article  PubMed  Google Scholar 

  2. Maruthur NM, Tseng E, Hutfless S, Wilson LM, Suarez-Cuervo C, Berger Z, Chu Y, Iyoha E, Segal JB, Bolen S (2016) Diabetes medications as monotherapy or metformin-based combination therapy for type 2 diabetes: a systematic review and meta-analysis. Ann Intern Med 164(11):740–751. https://doi.org/10.7326/M15-2650

    Article  PubMed  Google Scholar 

  3. Agresti A (2003) Categorical data analysis. Wiley

  4. Alomar MJ (2014) Factors affecting the development of adverse drug reactions. Saudi Pharmaceut J 22(2):83–94. https://doi.org/10.1016/j.jsps.2013.02.003

    Article  Google Scholar 

  5. Schütt M, Zimmermann A, Hood R, Hummel M, Seufert J, Siegel E, Tytko A, Holl R (2015) Gender-specific effects of treatment with lifestyle, Metformin or sulfonylurea on glycemic control and body weight: a German multicenter analysis on 9 108 patients. Exp Clin Endocrinol Diabetes 123(10):622–626. https://doi.org/10.1055/s-0035-1559608

    Article  CAS  PubMed  Google Scholar 

Download references

Code availability

Not applicable.

Author information

Authors and Affiliations

  1. Department of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran

    Zahra Rezaie

  2. Research Center for Rational Use of Drugs, Tehran University of Medical Sciences, 4th floor, No 92, Karimkhan Zand Ave., Hafte Tir Sq, Tehran, Iran

    Maryam Taghizadeh-Ghehi

  3. Department of Epidemiology and Biostatistics, Faculty of Health, Tehran University of Medical Sciences, Tehran, Iran

    Aarefeh Jafarzadeh Kohneloo

Authors
  1. Zahra Rezaie
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maryam Taghizadeh-Ghehi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Aarefeh Jafarzadeh Kohneloo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maryam Taghizadeh-Ghehi.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rezaie, Z., Taghizadeh-Ghehi, M. & Jafarzadeh Kohneloo, A. Are adverse drug reactions to anti-diabetic drugs more common in patients whose treatment do not adhere to diabetes management clinical guidelines? Comments on a study report. Eur J Clin Pharmacol 77, 1429–1430 (2021). https://doi.org/10.1007/s00228-021-03119-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-021-03119-8

Search

Navigation